Investors

Investors image

News

May.26, 2026 Notice
Notice of Convocation of the 161st Annual General Meeting of Shareholders
May.19, 2026 Release
Positive Interim Analysis Results from Phase 3 Clinical Trial of Tapinarof Cream 0.5%, Aryl Hydrocarbon Receptor (AhR) Modulating Agent, in Infant Patients with Atopic Dermatitis in Japan
May.15, 2026 Notice
Notice transcript of FY 2025 financial result meeting
May.14, 2026 Release
New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure
May.12, 2026 Notice
Financial Results and Supplement for FY2025
  • Latest IR Information

    ・Financial Results / Supplement

    　- Presentation material

    　- Transcript

    more
  • IR Library

    ・Financial Results / Supplement

    ・Presentation materials

    ・Annual Report / Integrated Report / EHS Report

    ・Corporate Governance Report

    ・Pipeline

    ・Fact Book

    more
  • Management Policy

    ・Philosophy

    ・Business Plan

    ・Corporate Governance

    ・Disclosure Policy

    ・Business Risks

    more
  • Shareholder Information

    ・Information on Shares

    ・General Meeting of Shareholders

    ・Analyst Coverage

    ・Bonds & Ratings

    more
  • Individual Investors

    ・Pharmaceutical Business

    ・Shionogi's Strength

    ・Business Strategy

    ・Business Activities, etc.

     

    more
  • Sustainability

    View the Shionogi's approach to sustainable growth

    more
  • Financial Highlights

    Financial highlights for the last five years

    more
  • IR Calendar

    The schedule and results of IR events in each fiscal year

     

    more